Home Report Store Hemostats Market

Hemostats Market Size, Share, Forecast, & Trends Analysis by Type (Gelatin, Collagen, Thrombin, Fibrin, Synthetic Sealant, Gauze) Form (Sheet, Powder, Gel) Application (Orthopedic, General, Cardiovascular, Dental, Trauma) End User - Global Forecast to 2031

Report ID:MRHC - 1041150 Pages: 280 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours

The Hemostats Market was valued at $3.11 billion in 2023. This market is expected to reach $5.32 billion by 2031, from an estimated $3.34 billion in 2024, at a CAGR of 6.9% during the forecast period 2024-2031.

Hemostats Market Size & Forecast

The growth of this market is driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular, orthopedic, and neurological diseases and subsequent increase in the volume of surgical procedures; increasing rate of accidents; rise in the number of cesarean deliveries, fatal injuries, and organ transplantation; increased R&D activities; rising healthcare spending; and growing preference for minimally invasive surgical procedures. Additionally, the increasing use of advanced hemostats, advancements in dental hemostatic agents, and increasing demand for preloaded applicators and ready-to-use hemostats are expected to offer significant market growth opportunities.

However, allergic reactions caused by the material used in making hemostats restrain the growth of this market. Additionally, the high manufacturing price for hemostats poses a significant challenge to the market's growth. Furthermore, biopolymer-based hemostats and dual-action hemostatic technology are trends prevailing in the hemostats market.

Hemostats Market Growth Drivers

Increasing Rate of Road Accidents

The rate of accidents has increased over the years. As per the U.S. Department of Health & Human Services, January 2023 report, road traffic crashes are among the leading causes of death in the U.S. Similarly, approximately 20,653 people were killed in road accidents in the EU, an increase of 3.7% compared to 2021 (Source: European Commission, Directorate-General for Communication). The increasing number of accidents has increased the number of hospital visits by patients for minor and major surgeries and wound care, driving the demand for hemostatic products in hospitals & clinics.

Growing Adoption of Minimally Invasive Surgical Procedures

The rate of minimally invasive surgeries (MIS) has been increasing in recent years. These surgeries necessitate tiny incisions, which creates demand for advanced hemostatic agents or tamponing agents to control blood loss.

With developments in minimally invasive surgery (MIS) approaches and technologies, MIS is becoming more popular in a variety of surgical disciplines, particularly cardiac surgery for coronary artery bypass surgery (CABG), valve surgery, and orthopedic surgery for hip and knee replacements. Furthermore, the adoption of minimally invasive surgeries is growing due to the benefits offered over traditional surgeries, such as easy and faster blood flow control, leading to shorter healing time and hospital stay, fewer complications, and less pain. Hemostats act as a powerful tool for surgeons to achieve hemostasis in these complicated surgeries. According to the American Society of Plastic Surgeons, in 2022, 682,932 non-invasive fat reduction surgeries and 408,970 non-invasive skin tightening surgeries were conducted in the U.S. Minimally invasive techniques frequently require operating complex cases as doctors limit the size and number of cuts or incisions. Hemostats created expressly for these procedures provide precision bleeding control, enabling surgeons to accomplish correct hemostasis.

Hemostats Market

Click here to: Get Free Sample Pages of this Report

Hemostats Market Trends

The Growing Popularity of Biopolymer-based Hemostats

Biopolymer-based hemostats are becoming popular in surgical hemostasis. These materials may assist with bleeding and come in a variety of forms, including particles, powder, sponges, sheets, foams, films, and hydrogels. Biopolymers have proven their applications as hemostatic materials due to their capabilities as biodegradable, biocompatible, and bioactive.

Biopolymer-based hemostats are meant to be biocompatible, which means the body easily absorbs them and does not trigger adverse reactions. The materials implemented in hemostats are selected with care to reduce the chance of immunological reactions and inflammation. Biopolymer-based hemostats provide a possible alternative to conventional hemostatic approaches. Their biocompatibility, absorbability, and hemostatic effectiveness make them particularly suitable choices for surgical treatments. As biopolymer technology research and development progresses, it is expected to bring more advances and higher adoption of biopolymer-based hemostats in clinical practice.

Dual-action hemostatic technology

Dual-action hemostatic technology effectively and promptly controls gingival bleeding. This technology approach ensures a comprehensive solution for managing bleeding during dental treatments. Dual-action hemostatic technology characteristics include effectivity and reliability, pose no biological risk in-vivo, are free from side effects, and stop bleeding quickly. Dual-action hemostatic technology achieves hemostasis in deep and complex wounds with secluded hemorrhagic sites. Additionally, the sealing capabilities provide suture support in vascular surgery, which is highly demanded by surgeons. Additionally, the rising preference for these hemostats is due to their dual mechanism of action, which involves the interaction of two different components which include collagen mediation of intrinsic hemostatic action liable to form fibrin clots and speedy adherence to applied tissue due to the electrophilic cross-linking with a protein-reactive polyethylene glycol monomer. Such advantages of dual-action hemostatic technology are expected to drive the hemostats market.

Hemostats Market Opportunity

The Advancements in Dental Hemostatic Agents

The use of hemostat products in dental procedures is a growing area of interest due to the advantages offered by various hemostatic agents, including gelatin-based hemostatic agents, owing to their biocompatibility, biodegradability, and low cost of raw materials. Many dental procedures, including exodontia, endosseous implantation, tissue biopsies, and periodontal surgery, have benefited due to the use of hemostats to control blood flow and its ability to reach inaccessible areas. Additionally, hemostats have been flexible to adapt to the wound and be removed easily without disintegrating into the bloodstream, owing to their increased demand in dental procedures. Furthermore, hemostats have been highly preferred by healthcare professionals to reduce increased healthcare expenditures for the patient and avoid unwanted postsurgical repair/infections associated with uncontrolled surgical bleeding. These factors have contributed to the growth of hemostats in dental procedures.

Hemostats Market Analysis: Key Findings

By Type: In 2024, the Absorbable Hemostats Segment to Dominate the Hemostats Market

Based on type, the hemostats market is segmented into absorbable hemostats and non-absorbable hemostats. In 2024, the absorbable hemostats segment is expected to account for the largest share of 58.6% of the hemostats market. The segment’s large share is attributed to the advantages offered by absorbable hemostats, such as controlling bleeding from fistula-puncture sites, achieving hemostasis during vascular surgery, controlling capillary bleeding, availability of versatile forms of hemostats, and rapid embolization.

However, the non-absorbable hemostats segment is projected to witness the highest growth rate of 7.6% during the forecast period of 2022–2031. This growth is driven by the growing use of fibrin sealants as hemostats by surgeons during surgery to physically provide an effective barrier for controlling blood flow. These sealants offer high biocompatibility, less time needed for clot formation, and the use of non-absorbable hemostats in high blood flow cases.

By Application: In 2024, the Surgery Market Segment to Dominate the Hemostats Market

Based on application, the hemostats market is segmented into surgery, dental treatments, and traumatic injury. In 2024, the surgery segment is expected to account for the largest share of the hemostats market. The segment’s large share is attributed to the recurrent use of various hemostatic agents in the increasing number of orthopedic, general, gynecological, and cardiovascular surgeries, the rising number of accidents and traumatic injuries leading to surgical treatments, and the use of advanced hemostats and advance sealants by healthcare professionals in minimally invasive surgeries for controlling the blood flow.

By Form: In 2024, the Matrix and Gel Segment Dominate the Hemostats Market

Based on form, the hemostats market is segmented into sponges and dressings, sheets and pads, powder, tools, and matrix and gel. In 2024, the matrix and gel segment is expected to account for the largest share of 41.3% of the hemostats market. The segment’s large share is attributed to advantages offered by matrix and gel hemostatic agents, such as the formation of a physical matrix, promoting activation of the clotting pathway; their wide applications in patients with intact coagulation cascade; availability of bioactive and biocompatible gels; and cost efficiency.

This segment is also projected to witness the highest growth rate of 7.2% during the forecast period of 2022–2031.

By End User: In 2024, the Hospitals & Clinics Segment to Dominate the Hemostats Market

Based on hospitals & clinics, the hemostats market is segmented into hospitals & clinics, ambulatory surgical centers, and nursing homes. In 2024, the hospitals & clinics segment is expected to account for the largest share of the hemostats market. The significant market share of this segment is attributed to the rising number of patient visits for surgical procedures and traumatic injury treatment in hospitals, the increasing number of surgeries, the willingness to spend on advance hemostats by hospitals, and favorable reimbursement policies.

Geographical Analysis

In 2024, North America is expected to account for the largest share of 32.9% of the hemostats market, followed by Europe and Asia-Pacific. In North America, the U.S. accounted for the largest share in 2024. The significant market share of the U.S. can be attributed to several key factors including the presence of key market players in the U.S., a well-established and technologically advanced healthcare infrastructure, and favorable government policies in the country.

Moreover, the market in Asia-Pacific is slated to register the highest growth rate (CAGR 7.8%) due to significantly growing markets such as India and China. The growth of this market is attributed to an increase in the number of acute injuries and accidents, an increase in surgical procedures in the countries, rising medical tourism, rising healthcare expenditures, and the focus of major players in these countries due to increasing market potential.

Hemostats Market: Key Companies

The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, financial growth, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the hemostats market are Baxter International Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), C. R. Bard, Inc.(U.S.), Integra LifeSciences (U.S.), Medtronic plc (Ireland), CSL Behring (U.K.), Gelita Medical GmbH (Germany), Grifols, S.A. (Spain), Abbott Laboratories (U.S.), CryoLife (U.S.), Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson.), Medtronic plc (Ireland), Becton, Dickinson and Company (BD) (U.S.), and Advanced Medical Solutions Group plc (U.K.). The Hemostats market is consolidated in nature, and the top 5-6 players accounted for a combined share of 40-50% in 2023.

Hemostats Market Industry Overview: Latest Developments from Key Industry Players

In July 2023, Baxter International Inc. (U.S.) launched PERCLOT Absorbable Hemostatic Powder in the U.S. The powder is a ready-to-use product that can be used for intact coagulation in mild bleeding cases.
In November 2023, Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson) received approval for ETHIZIA, an adjunctive hemostat solution that is proven to achieve sustained hemostasis to control excess bleeding situations.
In July 2021, Medcura, Inc. (U.S.), in partnership with ASO, LLC (U.S.), a manufacturer of first aid products, launched an antibacterial hemostatic gel named Rapid-Seal. The gel provides antibacterial and rapid bleeding management capabilities that aid in wound treatment.
In July 2021, Baxter International Inc. (U.S.), through its subsidiary Baxter Healthcare Corporation, acquired PerClot Polysaccharide Hemostatic System from CryoLife, Inc. (U.S.). The acquisition will strengthen Baxter’s product portfolio in hospitals, including operating rooms.
In October 2020, Teleflex Incorporated (U.S.) will acquire privately held Z-Medica, LLC (U.S.). Z-Medica’s hemostatic technologies aid in hemorrhage control, and end users worldwide are adopting efficient bleeding control solutions.

Hemostats Market Research Summary:

Particulars	Details
Number of Pages	~ 280
Format	PDF
Forecast Period	2024–2031
Base Year	2023
CAGR (Value)	6.9%
Market Size (Value)	USD 5.32 Billion by 2031
Segments Covered	By Type Absorbable Hemostats Mechanical or Passive Agents Gelatin-based Hemostat Collagen Hemostat Oxidized Regenerated Cellulose Hemostat Flowable and Active Agents Thrombin-based Hemostat Combination Hemostat Other Absorbable Hemostat Non-absorbable Hemostats Fibrin Sealants Synthetic Sealants Hemostatic Gauze Hemostatic Forceps By Application Surgery Orthopedic Surgery General Surgery Gynecology Surgery Cardiovascular Surgery Neurosurgery Plastic Surgery Other Surgeries Dental Treatments Traumatic Injury By Form Sponges and Dressings Sheets and Pads Powder Matrix and Gel Tools By End User Hospitals & Clinics Ambulatory Surgical Centers Nursing Homes
Countries Covered	North America (U.S., Canada), Europe (France, Germany, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
Key Companies	Baxter International Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), C. R. Bard, Inc. (U.S.), Integra LifeSciences (U.S.), Medtronic plc (Ireland), CSL Behring (U.K.), Gelita Medical GmbH (Germany), Grifols, S.A. (Spain), Abbott Laboratories (U.S.), CryoLife (U.S.), Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson.), Medtronic plc (Ireland), Becton, Dickinson and Company (BD) (U.S.), and Advanced Medical Solutions Group plc (U.K.).

Key questions answered in the hemostats market report:

What is the focus of the hemostats market study?

This study offers a detailed assessment of the hemostats market, including the market sizes & forecasts for market segments such as type, application, form, and end user. It also provides an in-depth analysis of various segments & subsegments of the hemostats market at the regional and country levels.

What is the size of the hemostats market, and at what CAGR is this market projected to grow during 2024–2031?

The hemostats market is projected to reach $5.32 billion by 2031, at a CAGR of 6.9% during the forecast period.

Which segment is expected to hold the major share of the market in 2024?

In 2024, the absorbable hemostats segment is expected to account for the largest market share. This segment's significant market share is attributed to its low cost, no risk of blood-borne diseases, super absorbent capacity, and use in dental procedures.

Which is the high-growth application segment of the hemostats Market?

In 2024, the surgery segment is expected to provide high growth, which can be attributed to factors such as the increasing number of surgeries in hospitals and ambulatory surgery centers, the increasing number of accidents, and the rise in cosmetic/plastic surgical procedures.

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the hemostats market?

The growth of this market is driven by the increasing volume of surgical procedures performed, high research and development in the surgical devices sector, increasing rate of accidents, increase in cesarean deliveries, fatal injuries, and organ transplantation, increased R&D activities by government organizations and the private sector, rising government healthcare spending, and growing adoption of minimally invasive surgical procedures.

Who are the major players operating in the hemostats market?

The key players profiled in the Hemostats market study are Baxter International Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), C. R. Bard, Inc.(U.S.), Integra LifeSciences (U.S.), Medtronic plc (Ireland), CSL Behring (U.K.), Gelita Medical GmbH (Germany), Grifols, S.A. (Spain), Abbott Laboratories (U.S.), CryoLife (U.S.), Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson.), Medtronic plc (Ireland), Becton, Dickinson and Company (BD) (U.S.), and Advanced Medical Solutions Group plc (U.K.).

Which regions/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?

Countries such as India and China are expected to offer significant growth opportunities for the vendors in this market due to factors such as the increasing adoption of hemostat solutions for surgical procedures, rising healthcare expenditures along with medical tourism in these countries, and the increasing number of accidents and chronic injuries.

Enquire

Check Discount

Related Tag: Hemostats Market Fibrin Sealant Hemostatic Forceps Hemostatic Gauze Sealant Surgical Hemostats Surgicel

Medical Technologies

Healthcare

1.   Introduction
1.1.   Market Definition & Scope
1.2.   Market Ecosystem
1.3.   Currency & Limitations
1.4.   Key Stakeholders
2.   Research Methodology
2.1.   Research Approach
2.2.   Data Collection and Validation Process
                  2.2.1.   Secondary Research
                  2.2.2.   Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3.   Market Sizing and Forecasting
                 2.3.1.   Market Size Estimation Approach
                 2.3.2.   Growth Forecast Approach
2.4.   Assumptions for the Study
3.   Executive Summary
4.   Factors Affecting Market Growth
4.1.   Overview
4.2.   Drivers
                  4.2.1.   Increasing Volume of Surgical Procedures Performed
                 4.2.2.   High Research and Development in Surgical Devices Sector
                 4.2.3.   Increasing Rate of Accidents
                 4.2.4.   Increase in Cesarean Deliveries, Fatal Injuries, and Organ Transplantation
                 4.2.5.   Increasing R&D Activities by Government Organizations and the Private Sector
                 4.2.6.   Rising Government Healthcare Spending
                  4.2.7.   Growing Adoption of Minimally Invasive Surgical Procedures
4.3.   Restraints
                  4.3.1.   Allergic Reactions Caused by the Material Used in Making Hemostats
4.4.   Opportunities
                  4.4.1.   Increasing Need to Control Blood Loss by Using Advanced Hemostats
                  4.4.2.   Advancements in Dental Hemostatic Agents
                  4.4.3.   Increasing Demand for Preloaded Applicators and Ready-to-Use Hemostats
4.5.   Challenges
                  4.5.1.   High Manufacturing Cost for Hemostasis
                  4.5.2. High Cost of Advanced Antimicrobial Hemostatic Agents
4.6.   Trends
                  4.6.1.   Biopolymer-based Hemostats
                 4.6.2.   Dual-Action Hemostatic Technology
4.7.   Factor Analysis
4.8.   Regulatory Analysis
4.9.   Pricing Analysis
4.10.   Case Studies
4.11.   Porter’s Five Forces Analysis
5.   Hemostats Market Assessment—by Type
5.1.   Overview
5.2.   Absorbable Hemostats
                  5.2.1.   Mechanical or Passive Agents
                   5.2.1.1.   Gelatin-based Hemostat
                   5.2.1.2.   Collagen Hemostat
                   5.2.1.3.   Oxidized Regenerated Cellulose Hemostat
                  5.2.2.   Flowable and Active Agents
                   5.2.2.1.   Thrombin-based Hemostat
                   5.2.2.2.   Combination Hemostat
                 5.2.3.   Other Absorbable Hemostats
5.3.   Non-absorbable Hemostats
                  5.3.1.   Fibrin Sealants
                  5.3.2.   Synthetic Sealants
                  5.3.3.   Hemostatic Gauze
                  5.3.4.   Hemostatic Forceps
6.   Hemostats Market Assessment—by Application
6.1.   Overview
6.2.   Surgery
                 6.2.1.   Orthopedic Surgery
                 6.2.2.   General Surgery
                 6.2.3.   Gynecology Surgery
                  6.2.4.   Cardiovascular Surgery
                  6.2.5.   Neurosurgery
                  6.2.6.   Plastic Surgery
                  6.2.7.   Other Surgeries
6.3.   Dental Treatments
6.4.   Traumatic Injury
7.   Hemostats Market Assessment—by Form
7.1.   Overview
7.2.   Sponges and Dressings
7.3.   Sheets and Pads
7.4.   Powder
7.5.   Matrix and Gel
7.6.   Tools
8.   Hemostats Market Assessment—by End User
8.1.   Overview
8.2.   Hospitals & Clinics
8.3.   Ambulatory Surgical Centers
8.4.   Nursing Homes
9.   Hemostats Market Assessment—by Geography
9.1.   Overview
9.2.   North America
                  9.2.1.   U.S.
                  9.2.2.   Canada
9.3.   Europe
                  9.3.1.   Germany
                   9.3.2.   France
                   9.3.3.   U.K.
                   9.3.4.   Italy
                   9.3.5.   Spain
                   9.3.6.   Switzerland
                   9.3.7.   Netherlands
                   9.3.8.   Rest of Europe (RoE)
9.4.   Asia-Pacific
                   9.4.1.   Japan
                   9.4.2.   China
                   9.4.3.   India
                   9.4.4.   Australia
                   9.4.5   South Korea
                   9.4.6.   Rest of Asia-Pacific (RoAPAC)
9.5.   Latin America
                   9.5.1.   Brazil
                  9.5.2.   Mexico
                  9.5.3.   Rest of Latin America (RoLATAM)
9.6.   Middle East & Africa
10.   Competition Analysis
10.1.   Overview
10.2.   Key Growth Strategies
10.3.   Competitive Benchmarking
10.4.   Competitive Dashboard
                  10.4.1.   Industry Leaders
                  10.4.2.   Market Differentiators
                  10.4.3.   Vanguards
                  10.4.4.   Emerging Companies
10.5.   Market Share Analysis/Market Rankings of Key Players (2023)
11.   Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1.   Baxter International Inc. (U.S.)
11.2.   Pfizer Inc. (U.S.)
11.3.   B. Braun Melsungen AG (Germany)
11.4.   C. R. Bard, Inc.(U.S.)
11.5.   Integra LifeSciences (U.S.)
11.6.   Medtronic plc (Ireland)
11.7.   CSL Behring (U.K.)
11.8.   Gelita Medical GmbH (Germany)
11.9.   Grifols, S.A. (Spain)
11.10.   Abbott Laboratories (U.S.)
11.11.   CryoLife (U.S.)
11.12.   Ethicon, Inc. (U.S.) (a subsidiary of Johnson & Johnson.)
11.13.   Medtronic plc (Ireland)
11.14.   Becton, Dickinson and Company (BD) (U.S.)
11.15.   Advanced Medical Solutions Group plc (U.K.)
   (Note: SWOT analysis of the top 5 companies will be provided.)
12.   Appendix
12.1.   Available Customization
12.2.   Related Reports

List of Tables
Table 1       Global Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 2       Global Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 3       Global Absorbable Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 4       Global Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 5       Global Mechanical or Passive Hemostatic Agents Market Size, by Country/Region, 2022–2031 (USD Million)
Table 6       Global Gelatin-based Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 7       Global Collagen Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 8       Global Oxidized Regenerated Cellulose Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 9       Global Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 10       Global Flowable and Active Hemostatic Agents Market Size, by Country/Region, 2022–2031 (USD Million)
Table 11       Global Thrombin-based Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 12       Global Combination Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 13       Global Other Absorbable Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 14       Global Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 15       Global Non-absorbable Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 16       Global Fibrin Sealants Market Size, by Country/Region, 2022–2031 (USD Million)
Table 17       Global Synthetic Sealants Market Size, by Country/Region, 2022–2031 (USD Million)
Table 18       Global Hemostatic Gauze Market Size, by Country/Region, 2022–2031 (USD Million)
Table 19       Global Hemostatic Forceps Market Size, by Country/Region, 2022–2031 (USD Million)
Table 20       Global Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 21       Global Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 22       Global Hemostats Market Size for Surgery, by Country/Region, 2022–2031 (USD Million)
Table 23       Global Hemostats Market Size for Orthopedic Surgery, by Country/Region, 2022–2031 (USD Million)
Table 24       Global Hemostats Market Size for General Surgery, by Country/Region, 2022–2031 (USD Million)
Table 25       Global Hemostats Market Size for Gynecology Surgery, by Country/Region, 2022–2031 (USD Million)
Table 26       Global Hemostats Market Size for Cardiovascular Surgery, by Country/Region, 2022–2031 (USD Million)
Table 27       Global Hemostats Market Size for Neurosurgery, by Country/Region, 2022–2031 (USD Million)
Table 28       Global Hemostats Market Size for Plastic Surgery, by Country/Region, 2022–2031 (USD Million)
Table 29       Global Hemostats Market Size for Other Surgeries, by Country/Region, 2022–2031 (USD Million)
Table 30       Global Hemostats Market Size for Dental Treatments, by Country/Region, 2022–2031 (USD Million)
Table 31       Global Hemostats Market Size for Traumatic Injury, by Country/Region, 2022–2031 (USD Million)
Table 32       Global Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 33       Global Hemostatic Sponges and Dressings Market Size, by Country/Region, 2022–2031 (USD Million)
Table 34       Global Hemostatic Sheets and Pads Market Size, by Country/Region, 2022–2031 (USD Million)
Table 35       Global Hemostatic Powders Market Size, by Country/Region, 2022–2031 (USD Million)
Table 36       Global Hemostatic Matrix and Gels Market Size, by Country/Region, 2022–2031 (USD Million)
Table 37       Global Hemostatic Tools Market Size, by Country/Region, 2022–2031 (USD Million)
Table 38       Global Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 39       Global Hemostats Market Size for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 40       Global Hemostats Market Size for Ambulatory Surgical Centers, by Country/Region, 2022–2031 (USD Million)
Table 41       Global Hemostats Market Size for Nursing Homes, by Country/Region, 2022–2031 (USD Million)
Table 42       Global Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 43       North America: Hemostats Market Size, by Country, 2022–2031 (USD Million)
Table 44       North America: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 45       North America: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 46       North America: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 47       North America: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 48       North America: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 49       North America: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 50       North America: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 51       North America: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 52       North America: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 53       U.S.: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 54       U.S.: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 55       U.S.: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 56       U.S.: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 57       U.S.: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 58       U.S.: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 59       U.S.: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 60       U.S.: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 61       U.S.: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 62       Canada: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 63       Canada: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 64       Canada: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 65       Canada: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 66       Canada: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 67       Canada: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 68       Canada: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 69       Canada: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 70       Canada: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 71       Europe: Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 72       Europe: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 73       Europe: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 74       Europe: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 75       Europe: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 76       Europe: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 77       Europe: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 78       Europe: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 79       Europe: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 80       Europe: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 81       Germany: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 82       Germany: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 83       Germany: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 84       Germany: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 85       Germany: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 86       Germany: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 87       Germany: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 88       Germany: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 89       Germany: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 90       France: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 91       France: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 92       France: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 93       France: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 94       France: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 95       France: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 96       France: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 97       France: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 98       France: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 99       U.K.: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 100   U.K.: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 101   U.K.: Mechanical or Passive Hemostats Agentic Market Size, by Type, 2022–2031 (USD Million)
Table 102   U.K.: Flowable and Active Hemostats Agentic Market Size, by Type, 2022–2031 (USD Million)
Table 103   U.K.: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 104   U.K.: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 105   U.K.: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 106   U.K.: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 107   U.K.: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 108   Italy: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 109   Italy: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 110   Italy: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 111   Italy: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 112   Italy: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 113   Italy: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 114   Italy: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 115   Italy: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 116   Italy: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 117   Spain: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 118   Spain: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 119   Spain: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 120   Spain: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 121   Spain: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 122   Spain: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 123   Spain: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 124   Spain: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 125   Spain: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 126   Netherlands: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 127   Netherlands: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 128   Netherlands: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 129   Netherlands: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 130   Netherlands: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 131   Netherlands: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 132   Netherlands: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 133   Netherlands: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 134   Netherlands: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 135   Switzerland: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 136   Switzerland: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 137   Switzerland: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 138   Switzerland: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 139   Switzerland: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 140   Switzerland: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 141   Switzerland: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 142   Switzerland: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 143   Switzerland: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 144   Rest of Europe (RoE): Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 145   Rest of Europe (RoE): Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 146   Rest of Europe (RoE): Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 147   Rest of Europe (RoE): Flowable and Active Hemostats Agentic Market Size, by Type, 2022–2031 (USD Million)
Table 148   Rest of Europe (RoE): Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 149   Rest of Europe (RoE): Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 150   Rest of Europe (RoE): Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 151   Rest of Europe (RoE): Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 152   Rest of Europe (RoE): Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 153   Asia-Pacific: Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 154   Asia-Pacific: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 155   Asia-Pacific: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 156   Asia-Pacific: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 157   Asia-Pacific: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 158   Asia-Pacific: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 159   Asia-Pacific: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 160   Asia-Pacific: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 161   Asia-Pacific: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 162   Asia-Pacific: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 163   Japan: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 164   Japan: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 165   Japan: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 166   Japan: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 167   Japan: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 168   Japan: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 169   Japan: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 170   Japan: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 171   Japan: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 172   China: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 173   China: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 174   China: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 175   China: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 176   China: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 177   China: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 178   China: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 179   China: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 180   China: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 181   India: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 182   India: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 183   India: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 184   India: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 185   India: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 186   India: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 187   India: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 188   India: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 189   India: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 190   Australia: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 191   Australia: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 192   Australia: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 193   Australia: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 194   Australia: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 195   Australia: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 196   Australia: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 197   Australia: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 198   Australia: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 199   South Korea: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 200   South Korea: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 201   South Korea: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 202   South Korea: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 203   South Korea: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 204   South Korea: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 205   South Korea: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 206   South Korea: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 207   South Korea: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 208   Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 209   Rest of Asia-Pacific (RoAPAC): Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 210   Rest of Asia-Pacific (RoAPAC): Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 211   Rest of Asia-Pacific (RoAPAC): Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 212   Rest of Asia-Pacific (RoAPAC): Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 213   Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 214   Rest of Asia-Pacific (RoAPAC): Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 215   Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 216   Rest of Asia-Pacific (RoAPAC): Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 217   Latin America: Hemostats Market Size, by Country/Region, 2022–2031 (USD Million)
Table 218   Latin America: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 219   Latin America: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 220   Latin America: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 221   Latin America: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 222   Latin America: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 223   Latin America: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 224   Latin America: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 225   Latin America: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 226   Latin America: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 227   Brazil: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 228   Brazil: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 229   Brazil: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 230   Brazil: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 231   Brazil: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 232   Brazil: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 233   Brazil: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 234   Brazil: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 235   Brazil: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 236   Mexico: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 237   Mexico: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 238   Mexico: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 239   Mexico: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 240   Mexico: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 241   Mexico: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 242   Mexico: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 243   Mexico: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 244   Mexico: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 245   Rest of Latin America (RoLA): Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 246   Rest of Latin America (RoLA): Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 247   Rest of Latin America (RoLA): Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 248   Rest of Latin America (RoLA): Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 249   Rest of Latin America (RoLA): Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 250   Rest of Latin America (RoLA): Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 251   Rest of Latin America (RoLA): Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 252   Rest of Latin America (RoLA): Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 253   Rest of Latin America (RoLA): Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 254   Middle East & Africa: Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 255   Middle East & Africa: Absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 256   Middle East & Africa: Mechanical or Passive Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 257   Middle East & Africa: Flowable and Active Hemostatic Agents Market Size, by Type, 2022–2031 (USD Million)
Table 258   Middle East & Africa: Non-absorbable Hemostats Market Size, by Type, 2022–2031 (USD Million)
Table 259   Middle East & Africa: Hemostats Market Size, by Application, 2022–2031 (USD Million)
Table 260   Middle East & Africa: Hemostats Market Size for Surgery, by Type, 2022–2031 (USD Million)
Table 261   Middle East & Africa: Hemostats Market Size, by Form, 2022–2031 (USD Million)
Table 262   Middle East & Africa: Hemostats Market Size, by End User, 2022–2031 (USD Million)
Table 263   Recent Developments, by Company, 2020–2024

List of Figures
Figure 1   Research Process
Figure 2   Key Secondary Sources
Figure 3   Primary Research Techniques
Figure 4   Key Executives Interviewed
Figure 5   Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6   Market Size Estimation Approach
Figure 7   Global Hemostats Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 8   Global Hemostats Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 9   Global Hemostats Market, by Form, 2024 Vs. 2031 (USD Million)
Figure 10   Global Hemostats Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 11   Global Hemostats Market, by Geography
Figure 12   Impact Analysis: Hemostats Market
Figure 13   Global Hemostats Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 14   Global Hemostats Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 15   Global Hemostats Market, by Form, 2024 Vs. 2031 (USD Million)
Figure 16   Global Hemostats Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 17   Global Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 18   North America: Hemostats Market Snapshot
Figure 19   Europe: Hemostats Market Snapshot
Figure 20   Asia-Pacific: Hemostats Market Snapshot
Figure 21   Latin America: Hemostats Market Snapshot
Figure 22   Key Growth Strategies Adopted by Leading Players (2020–2024)
Figure 23   Global Hemostats Market: Competitive Benchmarking, by Product
Figure 24   Global Hemostats Market: Competitive Benchmarking, by Geography
Figure 25   Global Hemostats Market: Vendor Dashboard
Figure 26   Global Hemostats Market: Market Share Analysis (2023)
Figure 27   Baxter International Inc.: Financial Overview (2023)
Figure 28   Pfizer Inc.: Financial Overview (2023)
Figure 29   B. Braun Melsungen AG: Financial Overview (2023)
Figure 30   Integra LifeSciences: Financial Overview (2023)
Figure 31   Medtronic plc: Financial Overview (2023)
Figure 32   CSL Behring: Financial Overview (2023)
Figure 33   Gelita Medical GmbH: Financial Overview (2023)
Figure 34   Grifols, S.A.: Financial Overview (2023)
Figure 35   Abbott Laboratories, Inc.: Financial Overview (2023)
Figure 36   CryoLife, Inc.: Financial Overview (2023)
Figure 37   Ethicon, Inc. (U.S.) (Subsidiary of Johnson & Johnson): Financial Overview (2023)
Figure 38   Becton, Dickinson and Company (BD): Financial Overview (2023)
Figure 39   Advanced Medical Solutions Group plc: Financial Overview (2023)

Enquire

Check Discount

Author Name:

Pranjali Takale, Mahesh Khillari

Related Tag: Hemostats Market Fibrin Sealant Hemostatic Forceps Hemostatic Gauze Sealant Surgical Hemostats Surgicel

Medical Technologies

Healthcare

This website is secure and we do not share your personal information with any third party. privacy policy

Proudly Partnering With Enterprises Around the Globe

Related Tag: Hemostats Market Fibrin Sealant Hemostatic Forceps Hemostatic Gauze Sealant Surgical Hemostats Surgicel

Request Sample

Customize My Report

Quick Contact

Chat on Whatsapp

Hemostats Market Size, Share, Forecast, & Trends Analysis by Type (Gelatin, Collagen, Thrombin, Fibrin, Synthetic Sealant, Gauze) Form (Sheet, Powder, Gel) Application (Orthopedic, General, Cardiovascular, Dental, Trauma) End User - Global Forecast to 2031

The Hemostats Market was valued at $3.11 billion in 2023. This market is expected to reach $5.32 billion by 2031, from an estimated $3.34 billion in 2024, at a CAGR of 6.9% during the forecast period 2024-2031.

Hemostats Market Size & Forecast